Michael Lotze Selected Research

Michael Lotze Research Topics

Disease

10	Neoplasms (Cancer) 01/2021 - 10/2007
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 11/2017
2	Adenocarcinoma 01/2020 - 11/2017
2	Neoplasm Metastasis (Metastasis) 11/2017 - 05/2012
2	Inflammation (Inflammations) 07/2015 - 05/2013
1	Carcinoma (Carcinomatosis) 01/2021
1	Carcinogenesis 01/2020
1	Necrosis 11/2017
1	Dementia (Dementias) 03/2017
1	Alzheimer Disease (Alzheimer's Disease) 03/2017
1	Glioma (Gliomas) 10/2016
1	Hepatocellular Carcinoma (Hepatoma) 07/2015
1	Liver Neoplasms (Liver Cancer) 07/2015
1	Hypoxia (Hypoxemia) 07/2015
1	Tuberculosis (Tuberculoses) 04/2014
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 04/2014
1	Extensively Drug-Resistant Tuberculosis 04/2014
1	Melanoma (Melanoma, Malignant) 10/2013
1	Breast Neoplasms (Breast Cancer) 10/2013
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 05/2013
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2012
1	Ischemia 08/2009
1	Reperfusion Injury 08/2009
1	Colorectal Neoplasms (Colorectal Cancer) 10/2007

Drug/Important Bio-Agent (IBA)

3	HMGB1 Protein (HMG1)IBA 07/2015 - 08/2009
2	CytokinesIBA 01/2021 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 07/2015 - 10/2013
2	VaccinesIBA 04/2014 - 10/2007
1	Interferon-gamma (Interferon, gamma)IBA 01/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021
1	Histones (Histone)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	dinaciclibIBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	STAT1 Transcription FactorIBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	ChemokinesIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	3- ((4- (6- bromo- 2- (4- (4- methylpiperazin- 1- yl)phenyl)- 3H- imidazo(4,5- b)pyridin- 7- yl)piperazin- 1- yl)methyl)- 5- methylisoxazoleIBA 11/2017
1	Aurora KinasesIBA 11/2017
1	Aurora Kinase AIBA 11/2017
1	NexusIBA 03/2017
1	isocitric acid (isocitrate)IBA 10/2016
1	Decitabine FDA Link 10/2016
1	LigandsIBA 10/2016
1	Oxidoreductases (Dehydrogenase)IBA 10/2016
1	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2015
1	Antigen-Antibody Complex (Immune Complex)IBA 07/2015
1	Toll-Like Receptor 9IBA 07/2015
1	Mitochondrial DNA (mtDNA)IBA 07/2015
1	Caspase 3 (Caspase-3)IBA 10/2013
1	Proteins (Proteins, Gene)FDA Link 10/2013
1	Recombinant ProteinsIBA 10/2013
1	IpilimumabIBA 10/2013
1	Interleukin-2 (IL2)IBA 10/2013
1	Fluorouracil (Carac)FDA LinkGeneric 10/2013
1	Toll-Like Receptor 4IBA 05/2013
1	Pattern Recognition ReceptorsIBA 05/2013
1	Imatinib Mesylate (Gleevec)FDA Link 05/2012
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2012
1	MicroRNAs (MicroRNA)IBA 05/2012
1	Cisplatin (Platino)FDA LinkGeneric 08/2009
1	Nuclear Proteins (Protein, Nuclear)IBA 08/2009
1	AntigensIBA 10/2007
1	Peptides (Polypeptides)IBA 10/2007
1	Interleukin-13IBA 10/2007
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2007

Therapy/Procedure

6	Therapeutics 01/2021 - 05/2012
2	Immunotherapy 01/2021 - 10/2013
1	Neoadjuvant Therapy 01/2020
1	Injections 11/2017
1	Subcutaneous Injections 11/2017
1	Oral Administration 11/2017